Inventor

CASTAIGNE JEAN-PAUL

CA8 patents

⚠️ This page may combine multiple inventors who share the name “CASTAIGNE JEAN-PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CASTAIGNE JEAN-PAUL

3 patents

US9173891B2Nov 3, 2015

Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog

CASTAIGNE JEAN-PAUL6 citations80

US9161988B2Oct 20, 2015

Multimeric peptide conjugates and uses thereof

CASTAIGNE JEAN-PAUL6 citations79

US8921314B2Dec 30, 2014

Conjugates of GLP-1 agonists and uses thereof

CASTAIGNE JEAN-PAUL5 citations69

CONJUCHEM LLC

1 patent

US8039432B2Oct 18, 2011

Method of treatment of diabetes and/or obesity with reduced nausea side effect

CONJUCHEM LLC38 citations90

DEMEULE MICHEL

1 patent

US8710013B2Apr 29, 2014

Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use

DEMEULE MICHEL5 citations68

SANOFI SA

1 patent

US4642306AFeb 10, 1987

Cyclic dithiodiacetamides and compositions containing them

SANOFI SA4 citations60

ANGIOCHEM INC

1 patent

US10980892B2Apr 20, 2021

Methods for the treatment of leptomeningeal carcinomatosis

ANGIOCHEM INC1 citations53

CASTAIGNE JEAN PAUL

1 patent

US9914754B2Mar 13, 2018

Conjugates of neurotensin or neurotensin analogs and uses thereof

CASTAIGNE JEAN PAUL0 citations47